Estadisticas : Safety, reactogenicity, and immunogenicity of MTBVAC in infants: a phase 2a randomised, double-blind, dose-defining trial in a TB endemic setting Tameris, Michele
Visitas:204
95 ( Estados Unidos de América )
47 ( Singapur )
15 ( Reino Unido )
13 ( Hong kong )
8 ( Finlandia )
5 ( Brasil )
4 ( India )
3 ( Alemania )
2 ( Rusia )
2 ( China )
2 ( España )
1 ( Líbano )
1 ( Venezuela )
1 ( Bélgica )
1 ( Colombia )
1 ( Honduras )
1 ( Uruguay )
1 ( Emiratos Árabes Unidos )
1 ( Arabia Saudita )
Descargas: 59